Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial - Frith, P A; Thompson, P J; Ratnavadivel, R (Thorax, 2015)
et al.